- Company List - S
- OCLS
Insider Trading activities at Sonoma Pharmaceuticals, Inc. (OCLS)
Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Sonoma Pharmaceuticals, Inc. (OCLS)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Sonoma Pharmaceuticals, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1367083.
Total stock buying since 2014: $151,209.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $0.
Table 1. Yearly summary of insider stock purchases, sales, and option exercises
at Sonoma Pharmaceuticals, Inc. (OCLS).
|
Insider Buying |
Insider Sales |
Option Exercises |
| Year |
Shares | Value |
Shares | Value |
Shares | Value |
| 2018 | 8,473 | $33,975 | 0 | $0 | 0 | $0 |
| 2017 | 11,882 | $67,002 | 0 | $0 | 0 | $0 |
| 2016 | 12,328 | $39,045 | 0 | $0 | 0 | $0 |
| 2014 | 6,285 | $11,187 | 0 | $0 | 0 | $0 |
Table 2. Monthly summary of insider trading at Sonoma Pharmaceuticals, Inc. (OCLS).
| Trading Period |
Insider Buying |
Insider Sales |
Option Exercises |
| year-month |
Shares | Value |
Shares | Value |
Shares | Value |
| 2018-03 | 8,473 | $33,975 | 0 | $0 | 0 | $0 |
| 2017-11 | 4,789 | $24,065 | 0 | $0 | 0 | $0 |
| 2017-08 | 3,793 | $20,253 | 0 | $0 | 0 | $0 |
| 2017-03 | 3,300 | $22,684 | 0 | $0 | 0 | $0 |
| 2016-12 | 6,000 | $29,180 | 0 | $0 | 0 | $0 |
| 2016-08 | 1,328 | $4,865 | 0 | $0 | 0 | $0 |
| 2016-02 | 5,000 | $5,000 | 0 | $0 | 0 | $0 |
| 2014-11 | 6,285 | $11,187 | 0 | $0 | 0 | $0 |
Table 3. Detailed insider trading at Sonoma Pharmaceuticals, Inc. (OCLS)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2018-03-13 | Miller Robert E (Chief Financial Officer) | Buy | 1,200 | 4.10 | 4,920 |
| 2018-03-12 | Miller Robert E (Chief Financial Officer) | Buy | 2,400 | 4.03 | 9,672 |
| 2018-03-09 | Miller Robert E (Chief Financial Officer) | Buy | 1,200 | 3.90 | 4,680 |
| 2018-03-08 | Schutz James J (Chief Executive Officer) | Buy | 2,473 | 3.99 | 9,867 |
| 2017-11-30 | Schutz James J (Chief Executive Officer) | Buy | 345 | 4.95 | 1,707 |
| 2017-11-29 | Miller Robert E (Chief Financial Officer) | Buy | 1,790 | 5.03 | 8,994 |
| 2017-11-29 | Schutz James J (Chief Executive Officer) | Buy | 400 | 5.03 | 2,012 |
| 2017-11-24 | Schutz James J (Chief Executive Officer) | Buy | 254 | 5.05 | 1,282 |
| 2017-11-21 | Miller Robert E (Chief Financial Officer) | Buy | 2,000 | 5.04 | 10,070 |
| 2017-08-10 | Umscheid Marc (Chief Strategy/Mkt Officer) | Buy | 600 | 5.31 | 3,185 |
| 2017-08-10 | Miller Robert E (Chief Financial Officer) | Buy | 2,264 | 5.30 | 11,999 |
| 2017-08-10 | Schutz James J (Chief Executive Officer) | Buy | 929 | 5.46 | 5,069 |
| 2017-03-09 | Miller Robert E (Chief Financial Officer) | Buy | 750 | 7.02 | 5,267 |
| 2017-03-08 | Miller Robert E (Chief Financial Officer) | Buy | 1,000 | 6.89 | 6,890 |
| 2017-03-06 | Umscheid Marc (Chief Strategy/Mkt Officer) | Buy | 750 | 6.82 | 5,115 |
| 2017-03-03 | Schutz James J (Chief Executive Officer) | Buy | 800 | 6.76 | 5,412 |
| 2016-12-08 | Miller Robert E (Chief Financial Officer) | Buy | 5,000 | 4.86 | 24,300 |
| 2016-12-08 | Schutz James J (Chief Executive Officer) | Buy | 1,000 | 4.88 | 4,880 |
| 2016-08-15 | Schutz James J (Chief Executive Officer) | Buy | 1,328 | 3.66 | 4,865 |
| 2016-02-25 | Schutz James J (Chief Executive Officer) | Buy | 5,000 | 1.00 | 5,000 |
| 2014-11-17 | Schutz James J (Chief Executive Officer) | Buy | 6,285 | 1.78 | 11,187 |
Insider trading activities including stock purchases, stock sales, and option exercises
of OCLS listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Sonoma Pharmaceuticals, Inc. (symbol OCLS,
CIK number 1367083) see
the Securities and Exchange Commission (SEC) website.